President Donald Trump just unveiled TrumpRx, a government-backed platform that allows Americans to buy some prescription drugs directly — bypassing insurers and pharmacy middlemen. Alongside that, Pfizer agreed to significant price cuts and will adopt most favored nation (MFN) pricing for future drug launches and Medicaid sales. In this short, we cover: What TrumpRx is and how it works The discounts Pfizer agreed to (40%–100%) on some drugs How MFN pricing will tie U.S. drug prices to those paid in other developed nations Pfizer’s $70B commitment to U.S. manufacturing and R&D Risks and open questions: import tariffs, excluded drugs, legal pushback, and whether the plan can scale Is this the turnaround U.S. drug pricing needed — or just a big political move? Share your take below. #Trump #pfizer #TrumpRx #Healthcare